Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomized placebo-controlled trial
Semaglutide and Tirzepatide can potentially cause inflammation of the pancreas, gallbladder problems, and even kidney issues
Its not exactly clear why this is an issue with tirzepatide and not with semaglutide
Seek immediate medical attention (call 999 or attend A&E) if tremors are accompanied by severe hypoglycaemia symptoms (confusion, loss of consciousness, seizures), chest pain, sudden weakness, speech difficulties, facial drooping, or severe headache with neck stiffness
About half of the participants received weekly 1-milligram injections of semaglutide the dose approved to treat type 2 diabetes under the brand name Ozempic in the US and the others got a placebo treatment